DEXTERITY-SCI
Subacute and Chronic Deep Vein Thrombosis (Iliac)
Phase 2Active
Key Facts
Indication
Subacute and Chronic Deep Vein Thrombosis (Iliac)
Phase
Phase 2
Status
Active
Company
About Mercator MedSystems
Mercator MedSystems is a private, clinical-stage medical device company pioneering targeted micro-infusion for vascular interventions. Founded in 2001 and based in San Leandro, California, the company's FDA-cleared Bullfrog device enables the localized delivery of drugs and biologics directly through vessel walls. Its lead clinical programs, the DEXTERITY trials in DVT and the TANGO trial in PAD, aim to address significant unmet needs by reducing chronic complications like post-thrombotic syndrome. The company is led by its inventor-founder, Dr. Kirk Seward, and is positioned in the growing field of interventional drug-device combination therapies.
View full company profile